Randomized controlled trial shows machine learning impact on distinguishing patient risk levels, suggesting improved decision-making.
This study suggests that clinical ML-based decision support tools may have the ability to influence care provider decisions and improve their capacity to rapidly differentiate between high- and low-risk patients at dispatch. Further research should establish the suitability of these tools in larger cohorts, for patients with both higher- and lower-levels of priority, and in other settings. The trial was registered at ClinicalTrials.gov (NCT04757194).
No takes yet. Share an insight, caveat, or question.
Spangler et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: